Use of recombinant factor viia for bleeding in children with Glanzmann thrombasthenia

被引:21
|
作者
Çaglar, K [1 ]
Çetinkaya, A [1 ]
Aytaç, S [1 ]
Gümrük, F [1 ]
Gürgey, A [1 ]
机构
[1] Hacettepe Univ, Fac Med, Dept Pediat, Pediat Hematol Unit, TR-06100 Ankara, Turkey
关键词
children; Glanzmann thrombastenia; recombinant factor VIIa;
D O I
10.1080/08880010390220135
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Glanzmann thrombasthenia is a very rare inherited platelet function disorder in which bleeding may be extremely difficult to stop. Recombinant factor VIIa is one of the alternative treatments for bleeding. The authors report here their experience with the use of factor VIIa, which may be useful for arresting bleeding in Glazmann thrombasthenia.
引用
收藏
页码:435 / 438
页数:4
相关论文
共 50 条
  • [31] The use of recombinant factor VIIa in a patient with severe Glanzmann's thrombasthenia to facilitate insertion of a Port-a-Cath®
    Ancliff, P
    Liesner, R
    Khair, K
    Hann, I
    BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 (07) : 447 - 448
  • [32] Use of recombinant factor VII in Glanzmann thrombasthenia: A case report
    Ben Abdallah, R. Chabchoub
    Trabelsi, L.
    Ben Ameur, S.
    Kammoun, F.
    Boukedi, A.
    Ben Salah, M.
    Ben Hlima, N.
    Mahfoudh, A.
    ARCHIVES DE PEDIATRIE, 2010, 17 (07): : 1062 - 1064
  • [33] The use of recombinant FVIIa in two children with Glanzmann's thrombasthenia with severe bleeding after trauma
    Gunes, A. Meral
    Evim, M. Sezgin
    Birol, B.
    HAEMOPHILIA, 2012, 18 : 148 - 148
  • [34] Recombinant factor VIIa for treatment of patients with Glanzmann thrombasthenia - a thrombin generation-based study
    Levy, Tamara
    Budnik, Ivan
    Barg, Assaf Arie
    Rosenberg, Nurit
    Seligsohn, Uri
    Kenet, Gili
    Livnat, Tami
    Levy-Mendelovich, Sarina
    HAEMOPHILIA, 2018, 24 : 99 - 99
  • [35] The impaired thrombin generation in patients with Glanzmann thrombasthenia can be corrected by recombinant factor VIIa (rFVIIa)
    Livnat, T.
    Martinowitz, U.
    Zivelin, A.
    Seligsohn, U.
    HAEMOPHILIA, 2008, 14 : 104 - 104
  • [36] Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing inversive procedures
    d'Oiron, R
    Ménart, C
    Trzeciak, MC
    Nurden, P
    Fressinaud, E
    Dreyfus, M
    Laurian, Y
    Négrier, C
    THROMBOSIS AND HAEMOSTASIS, 2000, 83 (05) : 644 - 647
  • [37] The use of recombinant FVIIa in a patient with Glanzmann thrombasthenia with uncontrolled bleeding after tonsillectomy
    Erduran, Erol
    Aksoy, Ayse
    Zaman, Dilek
    BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (03) : 215 - 217
  • [38] CASE REPORT: Successful Surgery Using Recombinant Factor VIIa for Recurrent, Idiopathic Nonulcer Duodenal Bleeding in a Patient with Glanzmann's Thrombasthenia
    Henk R. van Buuren
    Jenne J. Wielenga
    Digestive Diseases and Sciences, 2002, 47 : 2134 - 2136
  • [39] The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia
    Poon, Man-Chiu
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (03) : 332 - 340
  • [40] Low Concentrations of Recombinant Factor VIIa May Improve the Impaired Thrombin Generation of Glanzmann Thrombasthenia Patients
    Levy-Mendelovich, Sarina
    Levy, Tamara
    Budnik, Ivan
    Barg, Assaf Arie
    Rosenberg, Nurit
    Seligsohn, Uri
    Kenet, Gili
    Livnat, Tami
    THROMBOSIS AND HAEMOSTASIS, 2019, 119 (01) : 117 - 127